In a landmark study, researchers have used gene editing system CRISPR-Cas9 to treat a model of Duchenne muscular dystrophy in mice
Proof of concept for future human treatment
While safety is still a concern, the use of gene editing methods to treat disease in adult patients isn’t controversial. Altering embryos is entirely different to treating an adult, predominantly as the implications are profound and an embryo obviously cannot give permission.